Pacific Biosciences Of California reported $-81499000 in Pre-Tax Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Accelerate Diagnostics AXDX:US -14185000 8.57M
Bruker BRKR:US $ 111.6M 26.3M
Danaher DHR:US $ 2561.71M 44.71M
Fluidigm FLDM:US $ -76.86M 66.62M
Nanostring Technologies NSTG:US $ -39.42M 10.24M
Pacific Biosciences Of California PACB:US $ -81.5M 13.34M
Thermo Fisher Scientific TMO:US $ 3355M 760M
Waters WAT:US $ 200.12M 62.87M